NO173499C - Analogifremgangsmaate for fremstilling av terapeutisk aktive kinoxalinforbindelser - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive kinoxalinforbindelser

Info

Publication number
NO173499C
NO173499C NO873873A NO873873A NO173499C NO 173499 C NO173499 C NO 173499C NO 873873 A NO873873 A NO 873873A NO 873873 A NO873873 A NO 873873A NO 173499 C NO173499 C NO 173499C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
compounds
analogous procedures
quinoxaline compounds
Prior art date
Application number
NO873873A
Other languages
English (en)
Norwegian (no)
Other versions
NO173499B (no
NO873873L (no
NO873873D0 (no
Inventor
Tage Honore
Joergen Drejer
Poul Jacobsen
Flemming Elmelund Nielsen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO873873D0 publication Critical patent/NO873873D0/no
Publication of NO873873L publication Critical patent/NO873873L/no
Publication of NO173499B publication Critical patent/NO173499B/no
Publication of NO173499C publication Critical patent/NO173499C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO873873A 1986-09-16 1987-09-15 Analogifremgangsmaate for fremstilling av terapeutisk aktive kinoxalinforbindelser NO173499C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90786586A 1986-09-16 1986-09-16

Publications (4)

Publication Number Publication Date
NO873873D0 NO873873D0 (no) 1987-09-15
NO873873L NO873873L (no) 1988-03-17
NO173499B NO173499B (no) 1993-09-13
NO173499C true NO173499C (no) 1993-12-22

Family

ID=25424773

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873873A NO173499C (no) 1986-09-16 1987-09-15 Analogifremgangsmaate for fremstilling av terapeutisk aktive kinoxalinforbindelser

Country Status (12)

Country Link
EP (1) EP0260467B1 (de)
JP (1) JPS6383074A (de)
AT (1) ATE99296T1 (de)
CA (1) CA1298298C (de)
DE (1) DE3788612T2 (de)
DK (1) DK161319C (de)
ES (1) ES2061456T3 (de)
FI (1) FI88718C (de)
IE (1) IE66149B1 (de)
NO (1) NO173499C (de)
PT (1) PT85727B (de)
ZA (1) ZA876312B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK716188D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
HU221425B (en) * 1990-11-06 2002-10-28 Yamanouchi Pharma Co Ltd Condensed pyrazine derivatives, process for their production and pharmaceutical preparations containing these compounds
PT99864B (pt) * 1990-12-21 1999-06-30 Schering Ag Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato
DK73091D0 (da) * 1991-04-22 1991-04-22 Novo Nordisk As Quinoxalinforbindelser, deres fremstilling og anvendelse
DK0647137T3 (da) * 1992-06-22 2008-12-08 State Of Oregon Through Oregon Glycinreceptorantagonister og anvendelse deraf
AU688459B2 (en) * 1994-04-08 1998-03-12 Shionogi & Co., Ltd. Oxopyridinylquinoxaline derivative
DE4428152A1 (de) * 1994-06-22 1996-01-04 Basf Ag Neue Amido-chinoxalindione, ihrer Herstellung und Verwendung
AU3650695A (en) * 1994-09-30 1996-04-26 Basf Aktiengesellschaft New heterocyclic substituted imidazoloquinoxalinones, their preparation and their use
DE4436852A1 (de) * 1994-10-14 1996-04-18 Basf Ag Pyrrolyl-tetrahydrobenzochinoxalindione, ihre Herstellung und Verwendung
DE19521058A1 (de) * 1995-06-09 1996-12-12 Basf Ag Verfahren zur Herstellung von Aromaten enthaltenden Polyetherpolyolen
US5719153A (en) * 1995-08-15 1998-02-17 American Home Products Corporation 5H,8H-2-oxa-1,3,5,8-tetraaza-cyclopenta b!-naphthalene-6,7-diones
FR2743363A1 (fr) * 1996-01-10 1997-07-11 Rhone Poulenc Rorer Sa 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-a-ones substituees en position 2, leur preparation et les medicaments les contenant
DE19624808A1 (de) 1996-06-21 1998-01-02 Basf Ag Pyrrolylchinoxalindione, ihre Herstellung und Verwendung
EP3427729A1 (de) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid zur behandlung von epileptischen erkrankungen, störungen oder zuständen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992378A (en) * 1973-12-26 1976-11-16 Eli Lilly And Company Fluoralkyl quinoxadinediones
EP0107455B1 (de) * 1982-10-18 1986-07-09 Pfizer Inc. Triazoloquinoxaline als Antidepressions- und Antiermüdungsmittel

Also Published As

Publication number Publication date
NO173499B (no) 1993-09-13
DE3788612D1 (de) 1994-02-10
DK161319C (da) 1991-12-09
FI873790L (fi) 1988-03-17
DE3788612T2 (de) 1994-04-28
IE66149B1 (en) 1995-12-13
EP0260467B1 (de) 1993-12-29
DK471687A (da) 1988-03-17
FI873790A0 (fi) 1987-09-01
FI88718B (fi) 1993-03-15
NO873873L (no) 1988-03-17
PT85727A (en) 1987-10-01
NO873873D0 (no) 1987-09-15
ES2061456T3 (es) 1994-12-16
DK471687D0 (da) 1987-09-10
ATE99296T1 (de) 1994-01-15
ZA876312B (en) 1988-02-24
PT85727B (pt) 1990-08-31
JPH0532391B2 (de) 1993-05-14
EP0260467A2 (de) 1988-03-23
JPS6383074A (ja) 1988-04-13
IE872165L (en) 1988-03-16
CA1298298C (en) 1992-03-31
FI88718C (fi) 1993-06-28
EP0260467A3 (en) 1990-02-07
DK161319B (da) 1991-06-24

Similar Documents

Publication Publication Date Title
ES2062050T3 (es) Derivados de piperazinilo.
FI92582B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten kinoksaliinijohdannaisten valmistamiseksi
PT87552A (pt) Process for the preparation of novel tetrazole intermediates toantihypertensive compounds
FI843864A0 (fi) 2-amino-5-hydroxy-4 -metylpyrimidinderivat.
FI810604L (fi) Foerfarande foer framstaellning av indanderivat
DE68906609D1 (de) Dopamin-vorlaeufer.
EP0260467A3 (en) Quinoxaline compounds and their preparation and use
NO178661C (no) Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoksalinforbindelser
TNSN87012A1 (fr) Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
ATE71078T1 (de) Glyzerinderivate.
FR2378741A1 (fr) Acides garyl goxo isovaleriques doues de proprietes antiphlogistiques et antalgiques
NO164474C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heksahydropyrrolo(2,1-a)isokinolin-derivater.
DE3884878D1 (de) Uricosuretische Zusammensetzung.
FR2365569A1 (fr) Nouveaux acides carboxyliques pyrimido (1,2a)-heterocycliques, procede de preparation de ces corps et compositions pharmaceutiques qui les contiennent